Revenue: The sum of all revenue fields included for a company's operating activities.
Lexaria Bioscience Corp. (LEXX) had Revenue of $0.17M for the most recently reported fiscal quarter, ending 2025-08-31.
| Income Statement Financials | |
|
Revenue |
$0.17M |
$-2.70M |
|
-- |
|
$0.17M |
|
$2.86M |
|
$-2.69M |
|
$-0.01M |
|
$-2.70M |
|
$-2.69M |
|
$-2.70M |
|
$-2.70M |
|
$-2.70M |
|
$-2.69M |
|
$-2.69M |
|
$-2.67M |
|
18.00M |
|
18.00M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$3.47M |
|
$0.23M |
|
$0.71M |
|
$4.18M |
|
$1.49M |
|
-- |
|
$0.08M |
|
$1.57M |
|
$2.60M |
|
$2.29M |
|
$2.60M |
|
19.56M |
|
| Cash Flow Statement Financials | |
$-10.45M |
|
$-0.24M |
|
$6.05M |
|
$6.50M |
|
$1.80M |
|
$-4.70M |
|
$0.86M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1545.17% |
|
-1545.17% |
|
-- |
|
-1550.13% |
|
-1549.33% |
|
$-10.47M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
0.47 |
|
190.53 |
|
-103.63% |
|
-117.53% |
|
-64.60% |
|
-103.63% |
|
$0.13 |
|
$-0.58 |
|
$-0.58 |
|